RIXUBIS Drug Use-Result Survey (Japan)

Status Completed

Clinical Trial Summary

The purpose of this survey is to understand the following items observed in the actual clinical use of RIXUBIS. 1. Unexpected adverse drug reactions 2. Occurrence of adverse drug reactions in the actual clinical use 3. Factors that may affect safety and effectiveness 4. Occurrence of Factor IX (FIX) inhibitor development in patients with coagulation FIX deficiency 5. Safety and effectiveness for hemophilia B patients who received routine prophylactic therapy, on-demand therapy and perioperative therapy

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Hemophilia B

Clinical Trial Details

NCT number	NCT02937831
Study type	Observational
Source	Takeda
Contact
Status	Completed
Phase
Start date	November 16, 2016
Completion date	May 11, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04072237` - Study of Coagulation Faction VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia	Phase 1
Completed	`NCT02199717` - An Institutional Pilot Study to Investigate Physical Activity Patterns in Boys With Hemophilia	N/A
Completed	`NCT01662531` - A Safety, Efficacy and Pharmacokinetics Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Children With Hemophilia B	Phase 3
Completed	`NCT01335061` - Study To Compare On-Demand Treatment To A Prophylaxis Regimen Of BeneFIX In Subjects With Moderately Severe to Severe Hemophilia B	Phase 3
Completed	`NCT01217255` - Comparing the Burden of Illness of Hemophilia in the Developing and the Developed World
Completed	`NCT00037557` - Study Evaluating rFIX; BeneFIX in Severe Hemophilia B	Phase 3
Completed	`NCT02554773` - An Open-label Extension Study of an Investigational Drug, Fitusiran, in Patients With Moderate or Severe Hemophilia A or B	Phase 1/Phase 2
Terminated	`NCT02807753` - The Hemophilia Ultrasound Project
Active, not recruiting	`NCT03901755` - An International Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B
Not yet recruiting	`NCT05980377` - Patterns of Hemophilia Care in Assiut Children Patients
Recruiting	`NCT05687474` - Baby Detect : Genomic Newborn Screening
Terminated	`NCT03248141` - Understanding Hemophilia A and B Drug Dosage Administration Patterns
Terminated	`NCT01460147` - Osteoporosis and MRI Study in Hemophilia	N/A
Completed	`NCT03818529` - ATHN 8: Previously Untreated Patients (PUPs) Matter Study
Completed	`NCT02571569` - A Single Escalating Dose and Multiple Dose Study of BAY 1093884 in Subjects With Severe Hemophilia Types A or B, With or Without Inhibitors	Phase 1
Terminated	`NCT01620801` - Hemophilia B Gene Therapy With AAV8 Vector	Phase 1
Completed	`NCT01233440` - Safety and Pharmacokinetic Study of a Recombinant Coagulation Factor IX Albumin Fusion Protein in Subjects With Hemophilia B	Phase 1
Active, not recruiting	`NCT04135300` - Gene Therapy for Chinese Hemophilia B	N/A
Enrolling by invitation	`NCT03655223` - Early Check: Expanded Screening in Newborns
Terminated	`NCT00947193` - Study of Ataluren (PTC124) in Hemophilia A and B	Phase 2